The Impact of Clinical Trials in Patients with Multiple Myeloma and Lymphoma
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 17-002863
Sponsor Protocol Number: 17-002863
About this study
The purpose of this study is to evaluate quality of life over time in patients with multiple myeloma or lymphoma enrolled in clinical trials compared with patients on standard therapy.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria
- Age > 18 years
- Newly diagnosed or relapsed lymphoma or multiple myeloma starting on new therapy on clinical trial or off clinical trial
- Provide written informed consent
- Ability to complete questionnaire(s) in English by themselves or with assistance
Exclusion Criteria
- History of autologous bone marrow transplant in past three months
- History of allogeneic bone marrow transplant
- Undergoing active chemotherapy for any other cancer concomitantly
- Patients on single agent anti-CD20 antibodies alone
- ECOG performance status 3 or worse
- ANC < 1000
- Inadequate organ function (bilirubin > 2x UNL, GFR < 30 ml/min; decompensated congestive heart failure)
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Shaji Kumar, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available